Charlotte L.B.M. Korst - Publications, H-index & Citations

Back

Charlotte L.B.M. Korst

Amsterdam Institute for Infection and Immunology

7H-index

20Paper Count

91Citation Count

Published Papers 7

Publication Date

Monocyte-mediated metabolic rewiring via CD31-CD38 interactions promotes growth and drug-resistance in multiple myeloma

HemaSphere

IF14.6

2026-04-16

OAAI

Ramin Raoof; Giada Dal Collo; Helga Simon-Molas; Panagiota Tzortzi; Konxhe Kulaj; Elif N. Demirez; Crescenzo Massaro; Renée Poels; Charlotte L. B. M. Korst; Chloe A. O'Neill; Wassilis S. C. Bruins; Marloes E. C. Broekmans; Payam Behradkia; Maria Krevvata; Sonja Zweegman; Arnon P. Kater; Serena R. Baglio; Tuna Mutis; Niels W. C. J. van de Donk

Save

Sequencing BCMA- and GPRC5D-targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network

HEMASPHERE

IF14.6

2025-11-25

OAAI

van de Donk, Niels W. C. J.; Moreau, Philippe; San-Miguel, Jesus F.; Mateos, Maria-victoria; Dimopoulos, Meletios A.; Zweegman, Sonja; Gay, Francesca; Engelhardt, Monika; Mina, Roberto; Zamagni, Elena; Delforge, Michel; Beksac, Meral; Spencer, Andrew; Schjesvold, Fredrik; Driessen, Christoph; Kaiser, Martin; Perrot, Aurore; Wasch, Ralph; Korst, Charlotte L. B. M.; Broijl, Annemiek; Touzeau, Cyrille; Manier, Salomon; Hajek, Roman; Bila, Jelena; Seval, Guldane C.; O'dwyer, Michael; Ludwig, Heinz; Fernandez de Larrea, Carlos; Popat, Rakesh; Musto, Pellegrino; Rodriguez-Otero, Paula; Yong, Kwee; Kortum, Marin; Rasche, Leo; Terpos, Evangelos; Raab, Marc S.; Boccadoro, Mario; Sonneveld, Pieter; Einsele, Hermann

Save

Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myeloma

British Journal of Haematology

IF3.8

2025-11-03

OAAI

M. R. Seefat; D. G. J. Cucchi; L. van Boven; N. Durdu-Rayman; K. Groen; M.-D. Levin; K. de Heer; B. de Valk; R. Wester; E. van der Spek; R. Rentenaar; C. L. B. M. Korst; M. Quik; C. A. O'Neill; P. Tzortzi; F. Smits; R. Mathot; M. R. Heerma van Voss; N. W. C. J. van de Donk; T. Mutis; I. H. Bartelink; S. Zweegman

Save

Immune signatures in older patients with newly diagnosed multiple myeloma are associated with survival outcomes of first-line therapy irrespective of frailty levels

HemaSphere

IF14.6

2025-10-05

OAAI

Wassilis S. C. Bruins; Febe Smits; Carolien Duetz; Kazem Nasserinejad; Kazimierz Groen; Charlotte L. B. M. Korst; A. Vera de Jonge; Rosa Rentenaar; Tamara Hageman; Meliha Cosovic; Merve Eken; Inoka Twickler; Paola M. Homan-Weert; Christie P. M. Verkleij; Kristine Frerichs; Mark-David Levin; Ellen van der Spek; Inger S. Nijhof; Roel van Kampen; Niels W. C. J. van de Donk; Sonja Zweegman; Tuna Mutis

Save

A T-cell-based metric of immune age predicts outcomes in elderly myeloma patients receiving daratumumab-based therapy

Blood

IF23.1

2025-08-21

PREAI

Wassilis S. C. Bruins; Febe Smits; Carolien Duetz; Kaz Groen; Charlotte L. B. M. Korst; A. Vera de Jonge; Christie P. M. Verkleij; Rosa Rentenaar; Meliha Cosovic; Merve Eken; Inoka Twickler; Paola M. Homan-Weert; Pieter Sonneveld; Philippe Moreau; Jürgen Claesen; Niels W. C. J. van de Donk; Sonja Zweegman; Tuna Mutis

Save

T-cell redirecting bispecific antibody treatment in multiple myeloma: current knowledge and future strategies for sustained T-cell engagement

EXPERT OPINION ON BIOLOGICAL THERAPY

IF4

2024-09-01

OAAI

Heerma van Voss, Marise R.; Molenaar, Remco J.; Korst, Charlotte L. B. M.; Bartelink, Imke H.; Baglio, Serena R.; Kruyswijk, Sandy; de Ruijter, Maaike; Zweegman, Sonja; Kuipers, Maria T.; van de Donk, Niels W. C. J.

Save

Prophylactic tocilizumab reduces the incidence of cytokine release syndrome in relapsed/refractory myeloma patients treated with teclistamab: Implications for outpatient step-up dosing

HEMASPHERE

IF14.6

2024-07-24

OAAI

Korst, Charlotte L. B. M.; Groen, Kaz; Bosman, Patricia W. C.; van der Valk, Fleur; Verkleij, Christie P. M.; Kruyswijk, Sandy; de Ruijter, Maaike E. M.; Heijink, Dianne M.; Kuipers, Maria T.; Zweegman, Sonja; van de Donk, Niels W. C. J.

Save

Research Directions